Tratamiento en embarazos con desprendimiento prematuro de placenta normoinserta.

Abstract

Preterm detachment of the normoinsert placenta occurs after 20 weeks of gestation and is defined as separation by rupture of the blood vessels associated with abnormalities in placental development. It has a prevalence of 1 in every 100 to 120 pregnancies, of which 60% are at term, 35% during 32 to 36 weeks of gestation and 15% less than 32 weeks. This pathology accounts for 75% of maternal mortality and morbidity in countries such as the USA, Canada and Europe. There are several risk factors associated with placental abruption. Among these factors are: hypertensive disorders of pregnancy, abdominal trauma, consumption of toxic substances and thrombophilias. Therapeutic management will depend on the week of gestation and the maternal-fetal status. When there is fetal death, the objective is to reduce maternal mortality, in case of a live fetus at term, labor is indicated and when there is fetal compromise, cesarean delivery is indicated. Prenatal control, the identification of alarm signs such as vaginal bleeding, abdominal pain and uterine hypertonia, in addition to its complications such as hypovolemic shock, disseminated intravascular coagulation and Couvelaire uterus, are of great importance for the timely management of this pathology and in turn reduce maternal morbidity and mortality. The present project will be carried out by means of a bibliographic review of high impact articles on abortion.